CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 192 enrolled
Drug / intervention
Fluid Restriction Policy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00600704
NCT00600704N/ACompleted
CompareCT.gov

Impact of Fluid Restriction Policy Added to Intra-Operative Cell Salvage in Reducing the Use of Red Cells in Cardiac Surgery

Larissa University Hospital·interventional·Posted Jan 25, 2008·Updated Jun 7, 2011

In Brief

A clinical study evaluating Fluid Restriction Policy and Free fluid infusion for Coronary Artery Disease and 2 related conditions. Completed, enrolled 192 participants across 1 site.

Detailed Summary

The investigators' hypothesis is that restriction of circulating fluids in comparison to a liberal fluid administration policy would lead to a reduction of allogenic red blood cells exposure in patients undergoing cardiopulmonary bypass (CPB) for primary coronary artery bypass graft supported by reinfusion of washed shed blood from thoracic cavities.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Coronary Artery Bypass, Erythrocyte Transfusion
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 25, 2008
Enrollment StartNov 1, 2007
Primary CompletionNov 1, 2008
Study CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.4 years ago

Interventions

Fluid Restriction Policyprocedure

Infusion of Hes 130/0.4 up to 500 ml until the beginning of Cardiopulmonary bypass

Free fluid infusionprocedure

Free fluid infusion unless Hb\< 6g/dl(allogenic blood use), until the beginning of Cardiopulmonary bypass